| 0.3399 0 (0%) | 01-17 15:59 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 0.44 | 1-year : | 0.49 |
| Resists | First : | 0.37 | Second : | 0.41 |
| Pivot price | 0.34  |
|||
| Supports | First : | 0.31 | Second : | 0.25 |
| MAs | MA(5) : | 0.33 |
MA(20) : | 0.35 |
| MA(100) : | 0.36 |
MA(250) : | 0.4  |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 38.5 |
D(3) : | 30.7 |
| RSI | RSI(14): 44.8 | |||
| 52-week | High : | 0.91 | Low : | 0.27 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ IGC ] has closed above bottom band by 38.6%. Bollinger Bands are 18.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 0.35 - 0.35 | 0.35 - 0.35 |
| Low: | 0.33 - 0.33 | 0.33 - 0.33 |
| Close: | 0.34 - 0.34 | 0.34 - 0.34 |
India Globalization Capital, Inc. purchases and resells physical infrastructure commodities. It operates through two segments, Infrastructure and Life Sciences. The company rents heavy construction equipment, including motor grader and rollers; and undertakes highway construction contracts. It also develops cannabinoid-based products and therapies, such as hemp-based tinctures to treat anxiety, and enhance the lifestyle of patients suffering from Alzheimer's under the Hyalolex brand name; CBD based tinctures, capsules, and topical analgesic creams to treat pain under the Holief brand name; CBD powered beauty and skincare products under the Herbo brand name; and CBD infused beverages under the Sunday Seltzer brand. The company also engages in the wholesale of hemp extract under the Holi Hemp brand; production of products, such as lotions, creams, and oils, as well as white labeling support services; and extraction and distillation of crude oil into hemp extracts. It operates in the United States, India, Colombia, and Hong Kong. The company was incorporated in 2005 and is headquartered in Potomac, Maryland.
Mon, 13 Jan 2025
IGC Pharma to Participate in Fireside Chat with Ascendiant Capital Markets - Quantisnow
Fri, 26 Jul 2024
SEC charges Citron Capital, Andrew Left for $20 million stock recommendation scheme - Green Market Report
Wed, 12 Jun 2024
Anson Funds to pay $2.25 million for secret short seller relationship - Green Market Report
Wed, 12 Jun 2024
Toronto’s Anson Funds reaches settlement with U.S. regulator over short-selling practices - The Globe and Mail
Mon, 20 Mar 2023
IGC Announces Rebranding, Changes Name to IGC Pharma, Inc. - GlobeNewswire
Wed, 08 Dec 2021
Phase 1 Clinical Trial Provides Valuable Insights on Safe and Effective Dosing of IGC-AD1 for Alzheimer’s Patients - Business Wire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
AMEX
|
|
|
Sector:
Industrials
|
|
|
Industry:
Conglomerates
|
|
| Shares Out | 76 (M) |
| Shares Float | 69 (M) |
| Held by Insiders | 7.9 (%) |
| Held by Institutions | 21.6 (%) |
| Shares Short | 1,320 (K) |
| Shares Short P.Month | 1,170 (K) |
| EPS | -0.21 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.1 |
| Profit Margin | 0 % |
| Operating Margin | -871.4 % |
| Return on Assets (ttm) | -47.9 % |
| Return on Equity (ttm) | -126.2 % |
| Qtrly Rev. Growth | -51 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0.01 |
| EBITDA (p.s.) | -0.13 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -5 (M) |
| Levered Free Cash Flow | -4 (M) |
| PE Ratio | -1.62 |
| PEG Ratio | 0 |
| Price to Book value | 3.39 |
| Price to Sales | 24.25 |
| Price to Cash Flow | -4.7 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|